There have been a series of cases at (b)(6) hospital (b)(6) where the fda approved product (under the 510k clearance pathway): photofix decellularized bovine pericardium (intracardiac patch or pledget made of polypropylene, polyethylene terephthalate, or polytetrafluoroethylene) has been noted to have important loss in integrity to the point of recapitulating the original intracardiac lesions and in several cases requiring reoperation (via sternotomy) to repair.In the past 4 months, there have been 4 cases of photofix patches which have demonstrably failed (echocardiographically) requiring reoperation.Upon direct inspection during the reoperation, the photofix patches appeared to have been largely not intact and best described as disintegrated (loss of patch material).The patch failures could not be attributed to patient factors, infection, or surgical technique failures (i.E., suture failure).At our center, we have ceased to utilize photofix patches.We are currently undergoing a more extensive review of our patients who have undergone cardiac surgery utilize photofix patches.Our aim is to understand the potential incidence of patch failure (including patients who have experience patch failures but not to the degree as to requiring reoperations) and collaborate with other centers that may have similar experiences.Fda safety report id # (b)(4).
|